A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
CONCLUSIONS: LNG-IUS 8 and EE/DRSP were associated with similarly high user satisfaction rates. However, LNG-IUS 8 users were significantly more likely to prefer to continue their contraceptive method post-study, indicating that a levonorgestrel intrauterine system is an appealing contraceptive option for young women.
PMID: 27494570 [PubMed - as supplied by publisher]
Source: The European Journal of Contraception and Reproductive Health Care - Category: Reproduction Medicine Authors: Borgatta L, Buhling KJ, Rybowski S, Roth K, Rosen K Tags: Eur J Contracept Reprod Health Care Source Type: research
More News: Estradiol | Health | Health Management | Men | Mirena | Miscarriage | Pregnancy | Reproduction Medicine | Study | Women | Yasmin | Yaz